Key facts
- This page summarizes Brian Patrick McNulty's Form 4 filing for MIRA PHARMACEUTICALS, INC. (MIRA).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 30 Aug 2024, 16:05.
Brian Patrick McNulty - 28 Aug 2024 Form 4 Insider Report for MIRA PHARMACEUTICALS, INC. (MIRA)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- MIRA
- Reported as of
- 28 Aug 2024
- Net transaction value
- -$392,000
- SEC form
- 4
- Accepted by SEC
- 30 Aug 2024, 16:05:09 UTC
- Prior SEC filing
- 27 Dec 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Brian McNulty
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Brian Patrick McNulty filed Form 4 for MIRA PHARMACEUTICALS, INC. (MIRA) on 30 Aug 2024.
Change
- Previous filing in this sequence was filed on 27 Dec 2023.
- Current net transaction value: -$392,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MIRA
transaction
Common Stock
Sale
- Transaction value
- $392,000
- Shares
- -200,000
- Change %
- -7.3%
- Price
- $1.96
- Shares after
- 2,540,270
- Date
- 28 Aug 2024
- Ownership
- By Trust
- Footnotes
- F1
MIRA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 10,000
- Date
- 28 Aug 2024
- Ownership
- Direct
- Footnotes
- F2
MIRA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 660,000
- Date
- 28 Aug 2024
- Ownership
- By Trust
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
As trustee of the Bay Shore Trust and the Celeste J Williams Lifetime QTIP Trust, Mr. McNulty has sole voting and dispositive power over the shares held by each trust, and, as a result is deemed to have beneficial ownership (as determined under Section 13(d) of the Exchange Act) of the securities held by the trusts. The address for the Bay Shore Trust is 900 West Platt Street, Suite 200, Tampa, Florida, 33606.
Footnote F2
These securities are owned directly by Mr. McNulty